Pure Global

LH Rapid Quantitative Test - India CDSCO Medical Device Registration

LH Rapid Quantitative Test is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2022/000074_c271250174a347e97511d75fd8da758b_11545d038466454d50eab9e250378280. This device is marketed under the brand name Glycated Hemoglobin. The license holder is FINOVA HEALTHCARE PRIVATE LIMITED, and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
LH Rapid Quantitative Test
UID: IMP/IVD/2022/000074_c271250174a347e97511d75fd8da758b_11545d038466454d50eab9e250378280

Brand Name

Glycated Hemoglobin

Device Class

Class B

Approving Authority

CDSCO

Product Information

The LH Rapid Quantitative Test along with Aehealth FIA Meter is intended for vitro quantitative determination of Luteinizing Hormone๏ผˆ LH๏ผ‰ in human whole blood, serum or plasma. This test is used as an aid to diagnose the ovulation cycle, premature ovarian failure and gonadal hypoplasia

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing